Literature DB >> 22524894

Oral HPV infection and MHC class II deficiency (A study of two cases with atypical outcome).

Naouel Guirat-Dhouib1, Yemen Baccar, Imène Ben Mustapha, Monia Ouederni, Sameh Chouaibi, Nadia El Fekih, Mohamed Ridha Barbouche, Bassima Fezaa, Ridha Kouki, Slama Hmida, Fethi Mellouli, Mohamed Bejaoui.   

Abstract

BACKGROUND: Major histocompatibility complex class II deficiency, also referred to as bare lymphocyte syndrome is a rare primary Immunodeficiency disorder characterized by a profondly deficient human leukocyte antigen class II expression and a lack of cellular and humoral immune responses to foreign antigens. Clinical manifestations include extreme susceptibility to viral, bacterial, and fungal infections. The infections begin in the first year of life and involve usually the respiratory system and the gastrointestinal tract. Severe malabsorption with failure to thrive ensues, often leading to death in early childhood. Bone marrow transplantation is the curative treatment. CASE REPORTS: Here we report two cases with a late outcome MHC class II deficiency. They had a long term history of recurrent bronchopulmonary and gastrointestinal infections. Bone marrow transplantation could not be performed because no compatible donor had been identified. At the age of 12 years, they developed oral papillomatous lesions related to HPV (human papillomavirus). The diagnosis of HPV infection was done by histological examination. HPV typing performed on the tissue obtained at biopsy showed HPV type 6. The lesions were partially removed after two months of laser treatment.
CONCLUSIONS: Viral infections are common in patients with MHC class II and remain the main cause of death. Besides warts caused by HPV infection do not exhibit a propensity for malignant transformation; they can cause great psychosocial morbidity.

Entities:  

Year:  2012        PMID: 22524894      PMCID: PMC3349517          DOI: 10.1186/1476-7961-10-6

Source DB:  PubMed          Journal:  Clin Mol Allergy        ISSN: 1476-7961


  11 in total

1.  Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B.

Authors:  W Wiszniewski; M C Fondaneche; N Lambert; K Masternak; C Picard; L Notarangelo; K Schwartz; J Bal; W Reith; C Alcaide; G de Saint Basile; A Fischer; B Lisowska-Grospierre
Journal:  Immunogenetics       Date:  2000-04       Impact factor: 2.846

Review 2.  MHC class II deficiency: a disease of gene regulation.

Authors:  J Villard; K Masternak; B Lisowska-Grospierre; A Fischer; W Reith
Journal:  Medicine (Baltimore)       Date:  2001-11       Impact factor: 1.889

Review 3.  Hematopoietic stem cell transplantation and other management strategies for MHC class II deficiency.

Authors:  Capucine Picard; Alain Fischer
Journal:  Immunol Allergy Clin North Am       Date:  2010-05       Impact factor: 3.479

Review 4.  MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: case report and review of 68 cases in the literature.

Authors:  M Siepermann; S Gudowius; K Beltz; U Strier; O Feyen; A Troeger; U Göbel; H J Laws; G Kögler; R Meisel; D Dilloo; T Niehues
Journal:  Pediatr Transplant       Date:  2010-03-04

5.  Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.

Authors:  Monia Ouederni; Quentin B Vincent; Pierre Frange; Fabien Touzot; Sami Scerra; Mohamed Bejaoui; Aziz Bousfiha; Yves Levy; Barbara Lisowska-Grospierre; Danielle Canioni; Julie Bruneau; Marianne Debré; Stéphane Blanche; Laurent Abel; Jean-Laurent Casanova; Alain Fischer; Capucine Picard
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

6.  HLA-DR alleles associated with skin warts induced by human papillomavirus infection.

Authors:  Cristina García-Corona; Elisa Vega-Memije; Rodrigo Barquera; Julio Granados
Journal:  Int J Dermatol       Date:  2010-12       Impact factor: 2.736

7.  Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99.

Authors:  Corinne Antoine; Susanna Müller; Andrew Cant; Marina Cavazzana-Calvo; Paul Veys; Jaak Vossen; Anders Fasth; Carsten Heilmann; Nicolas Wulffraat; Reinhard Seger; Stéphane Blanche; Wilhelm Friedrich; Mario Abinun; Graham Davies; Robert Bredius; Ansgar Schulz; Paul Landais; Alain Fischer
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

8.  Human papillomavirus in the oral cavities of children and adolescents.

Authors:  K F Summersgill; E M Smith; B T Levy; J M Allen; T H Haugen; L P Turek
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2001-01

9.  Human leukocyte antigen class II alleles and natural history of HPV 2/27/57-induced common warts.

Authors:  Bettina Spelten; Elke-Ingrid Grussendorf-Conen; Albert Rübben
Journal:  Arch Dermatol Res       Date:  2004-07-15       Impact factor: 3.017

10.  Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome.

Authors:  C Klein; B Lisowska-Grospierre; F LeDeist; A Fischer; C Griscelli
Journal:  J Pediatr       Date:  1993-12       Impact factor: 4.406

View more
  6 in total

Review 1.  Inborn errors in immunity: unique natural models to dissect oral immunity.

Authors:  N M Moutsopoulos; M S Lionakis; G Hajishengallis
Journal:  J Dent Res       Date:  2015-04-21       Impact factor: 6.116

Review 2.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

Review 3.  Human genetic dissection of papillomavirus-driven diseases: new insight into their pathogenesis.

Authors:  Vivien Béziat
Journal:  Hum Genet       Date:  2020-05-20       Impact factor: 4.132

4.  Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients.

Authors:  Imen Ben-Mustapha; Khaoula Ben-Farhat; Naouel Guirat-Dhouib; Emna Dhemaied; Beya Larguèche; Meriem Ben-Ali; Jalel Chemli; Jihène Bouguila; Lamia Ben-Mansour; Fethi Mellouli; Monia Khemiri; Mohamed Béjaoui; Mohamed-Ridha Barbouche
Journal:  J Clin Immunol       Date:  2013-01-13       Impact factor: 8.317

5.  Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status.

Authors:  Annekatrin Coordes; Klaus Lenz; Xu Qian; Minoo Lenarz; Andreas M Kaufmann; Andreas E Albers
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-31       Impact factor: 2.503

6.  Cutaneous Manifestations of Primary Immunodeficiency Diseases in Tunisian Children.

Authors:  Naouel Guirat Dhouib; Monia Ben Khaled; Monia Ouederni; Imen Ben-Mustapha; Ridha Kouki; Habib Besbes; Mohamed Ridha Barbouche; Fethi Mellouli; Mohamed Bejaoui
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-11-01       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.